Connect public, paid and private patent data with Google Patents Public Datasets

Screening test and procedure using skin patches

Info

Publication number
WO2002095401A3
WO2002095401A3 PCT/US2001/044319 US0144319W WO2002095401A3 WO 2002095401 A3 WO2002095401 A3 WO 2002095401A3 US 0144319 W US0144319 W US 0144319W WO 2002095401 A3 WO2002095401 A3 WO 2002095401A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
disease
sweat
indicate
markers
physiological
Prior art date
Application number
PCT/US2001/044319
Other languages
French (fr)
Other versions
WO2002095401A2 (en )
Inventor
Stuart Berlin
Original Assignee
Stuart Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/528Atypical element structures, e.g. gloves, rods, tampons, toilet paper
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate

Abstract

Marker compounds indicative of variations in physiological conditions, genetic defects or disease states have been found to be present in spocrine sweat and, in many conditions, these markers are present in apocrine sweat in elevated levels when compared to blood. These markers are collected and/or detected in apocrine sweat and used as an indicator that a disease state or particular physiological condition exists. A skin patch, wipe or electronic detector for vapors released from spocrine sweat are used to indicate the existence of a disease state or changing physiological condition. The patch or wipe can include in monoclonal antibodies or other chemical compounds that can indicate the presence of specific markers. This may include indicators that render visible, the existence of a reaction between the monoclonal antibody or chemical compound and the marker compound to indicate the existence of the condition being tested for. Various different disease states can be detected including, but not limited to heart disease, cancer, autoimmune disease, viral or bacterial disease, renal disease, drug intoxication and other systemic illnesses. Fertility for conception and histocompatibility for organ transplantation of individuals should also be detectable.
PCT/US2001/044319 2000-11-29 2001-11-27 Screening test and procedure using skin patches WO2002095401A3 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US25020600 true 2000-11-29 2000-11-29
US60/250,206 2000-11-29
US09994535 US6585646B2 (en) 2000-11-29 2001-11-26 Screening test and procedure using skin patches

Publications (2)

Publication Number Publication Date
WO2002095401A2 true WO2002095401A2 (en) 2002-11-28
WO2002095401A3 true true WO2002095401A3 (en) 2003-08-28

Family

ID=26940684

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/044319 WO2002095401A3 (en) 2000-11-29 2001-11-27 Screening test and procedure using skin patches

Country Status (2)

Country Link
US (2) US6585646B2 (en)
WO (1) WO2002095401A3 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133024B2 (en) * 2003-09-03 2015-09-15 Brigitte Chau Phan Personal diagnostic devices including related methods and systems
US20050283380A1 (en) * 2004-06-18 2005-12-22 Garduno Ramon S Delivery service for a health management system
JP2009543076A (en) * 2006-07-11 2009-12-03 ブロックウェル,ポール ナイジェルBROCKWELL,Paul Nigel Indicator system for measuring an analyte concentration
US20080103823A1 (en) * 2006-11-01 2008-05-01 Papa Angelo A Method for coordinating professional services
US20120046964A1 (en) * 2007-10-30 2012-02-23 Papa Angelo A Method of coordinating professional services
CA2694120A1 (en) * 2007-06-22 2008-12-31 Expression Pathology Method of discovering and analyzing secreted biomarkers of disease from solid tissue
US20120165626A1 (en) * 2009-07-13 2012-06-28 Irina Finkelshtein V Devices, methods, and kits for determining analyte concentrations
CN102687323B (en) 2009-12-22 2015-09-30 3M创新有限公司 The fuel cell sub-assembly using subgasket economizer film
WO2015066459A1 (en) * 2013-10-31 2015-05-07 Medtech Bioscience, Llc Analyte detection device and methods of using same
GB2535614B (en) * 2015-12-22 2017-06-14 Tfm Invent Ltd A skin patch

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868106A (en) * 1985-10-17 1989-09-19 Konishiroku Photo Industry Co., Ltd. Analytical element and method for determining a component in a test sample
EP0737442A1 (en) * 1992-12-07 1996-10-16 Hisamitsu Pharmaceutical Co. Inc. Plaster for testing and method of testing
EP0811847A2 (en) * 1996-06-05 1997-12-10 Boehringer Mannheim Gmbh Method for detection of analytes on a surface
US5891649A (en) * 1996-08-08 1999-04-06 California Institute Of Technology Real-time biochemical assay telemetering system
DE29902593U1 (en) * 1999-02-13 1999-07-15 Genzyme Virotech Gmbh Gas analyzer for medical diagnostics
US5944662A (en) * 1988-09-08 1999-08-31 Sudormed, Inc. Method and apparatus of determination of chemical species in perspiration
US6042543A (en) * 1997-03-11 2000-03-28 Regents Of The University Of Minnesota Test device and method for quantitative measurement of an analyte in a liquid

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3552929A (en) 1968-01-23 1971-01-05 Minnesota Mining & Mfg Diagnosis means
US4329999A (en) 1980-03-03 1982-05-18 Michael Phillips Patient attached patch and method of making
US4444193A (en) * 1982-01-11 1984-04-24 Medtronic, Inc. Fluid absorbent quantitative test device
US4732153A (en) * 1984-07-18 1988-03-22 Michael Phillips Transdermal dosimeter
US4931403A (en) * 1985-01-25 1990-06-05 Monell Chemical Senses Center Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators
US4706676A (en) 1985-02-11 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Dermal substance collection device
US5459080A (en) 1988-01-29 1995-10-17 Abbott Laboratories Ion-capture assays using a specific binding member conjugated to carboxymethylamylose
US5465713A (en) 1988-09-08 1995-11-14 Sudor Partners Energy-assisted transdermal collection patch for accelerated analyte collection and method of use
US5203327A (en) * 1988-09-08 1993-04-20 Sudor Partners Method and apparatus for determination of chemical species in body fluid
US4957108A (en) 1988-09-08 1990-09-18 Sudor Partners Method and apparatus for determination of chemical species in body fluid
US5445147A (en) 1988-09-08 1995-08-29 Sudor Partners Method and apparatus for determination of chemical species in body fluid
US5076273A (en) 1988-09-08 1991-12-31 Sudor Partners Method and apparatus for determination of chemical species in body fluid
US6040194A (en) 1989-12-14 2000-03-21 Sensor Technologies, Inc. Methods and device for detecting and quantifying substances in body fluids
US5470970A (en) 1991-02-28 1995-11-28 Dana-Farber Cancer Institute, Inc. Maspin, a serpin with tumor suppresing activity
US5443080A (en) * 1993-12-22 1995-08-22 Americate Transtech, Inc. Integrated system for biological fluid constituent analysis
WO1996032142A1 (en) 1995-04-12 1996-10-17 Hopp Robert B Skin patch for use in contact immunotherapy
US5525521A (en) * 1995-06-15 1996-06-11 Borrego Analytical, Inc. Cystic fibrosis tester
US6143529A (en) * 1996-08-14 2000-11-07 Exact Laboratories, Inc. Methods for improving sensitivity and specificity of screening assays
US5798266A (en) 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
US5911976A (en) * 1996-10-24 1999-06-15 The Procter & Gamble Company Compositions for reducing body odor
WO1998059361A1 (en) * 1997-06-20 1998-12-30 Ciphergen Biosystems, Inc. Retentate chromatography and protein chip arrays with applications in biology and medicine
US5895765A (en) 1997-06-30 1999-04-20 Bayer Corporation Method for the detection of an analyte by immunochromatography
US6479015B1 (en) * 1998-03-03 2002-11-12 Pepex Biomedical, Llc Apparatus for monitoring a level of a chemical species in a body fluid
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
US6680203B2 (en) * 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
US6443892B1 (en) * 2000-09-28 2002-09-03 The United States Of America As Represented By The Secretary Of The Navy Sweat collecting device and methods for use and detection of tampering

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868106A (en) * 1985-10-17 1989-09-19 Konishiroku Photo Industry Co., Ltd. Analytical element and method for determining a component in a test sample
US5944662A (en) * 1988-09-08 1999-08-31 Sudormed, Inc. Method and apparatus of determination of chemical species in perspiration
EP0737442A1 (en) * 1992-12-07 1996-10-16 Hisamitsu Pharmaceutical Co. Inc. Plaster for testing and method of testing
EP0811847A2 (en) * 1996-06-05 1997-12-10 Boehringer Mannheim Gmbh Method for detection of analytes on a surface
US5891649A (en) * 1996-08-08 1999-04-06 California Institute Of Technology Real-time biochemical assay telemetering system
US6042543A (en) * 1997-03-11 2000-03-28 Regents Of The University Of Minnesota Test device and method for quantitative measurement of an analyte in a liquid
DE29902593U1 (en) * 1999-02-13 1999-07-15 Genzyme Virotech Gmbh Gas analyzer for medical diagnostics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BALABANOVA S ET AL: "[Detection of drugs in sweat]", BEITRAGE ZUR GERICHTLICHEN MEDIZIN. AUSTRIA 1990, vol. 48, 1990, pages 45 - 49, XP009009462, ISSN: 0067-5016 *

Also Published As

Publication number Publication date Type
WO2002095401A2 (en) 2002-11-28 application
US6585646B2 (en) 2003-07-01 grant
US20020115921A1 (en) 2002-08-22 application
US20030199743A1 (en) 2003-10-23 application

Similar Documents

Publication Publication Date Title
Mammen et al. PFA-100™ system: a new method for assessment of platelet dysfunction
Garcia‐Tsao et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding
Connell et al. Lower gastrointestinal malignancy in Crohn's disease.
Thike et al. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer
Berois et al. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR
US7150995B2 (en) Methods and systems for point of care bodily fluid analysis
Ahmed et al. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome
Bruze et al. Thoughts on sensitizers in a standard patch test series
Baloch et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.
Winssinger et al. Profiling protein function with small molecule microarrays
US6281004B1 (en) Quality control for cytochemical assays
Meadway et al. Opiate concentrations following the ingestion of poppy seed products–evidence forthe poppy seed defence'
US6410341B1 (en) Analytical test device and method for use in medical diagnoses
Randall et al. Elevated postmortem tryptase in the absence of anaphylaxis
Ruprah et al. Acute carbon tetrachloride poisoning in 19 patients: implications for diagnosis and treatment
Mooradian Digitalis
Echimane et al. Cancer incidence in Abidjan, Ivory Coast
Wickström et al. Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients
Cuzick et al. Long‐term follow‐up of cervical abnormalities among women screened by HPV testing and cytology—Results from the Hammersmith study
Durante et al. Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma
Songster et al. Immunochemical detection of fecal occult blood–. The fecal smear punch‐disc test: A new non‐invasive screening test for colorectal cancer
Knopp Application of immunological methods for the determination of environmental pollutants in human biomonitoring. A review
Rapkiewicz et al. The needle in the haystack: Application of breast fine‐needle aspirate samples to quantitative protein microarray technology
Apple et al. Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction
Haehling et al. Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP